HIV in prison: what are the risks and what can be done?

Prisons are recognised worldwide as important sites for transmission of blood-borne viruses (BBVs). There are two reasons why transmission risks in prison are higher than in the community. First, in most western countries, many prison entrants have histories of injecting drug use, and thus already have high prevalences of BBVs. Second, the lack or under-supply of preventive measures (such as clean needle and syringes or condoms) in most prisons, combined with extreme social conditions, creates extra opportunities for BBV transmission. HIV prevalence in prisoners in more developed countries ranges from 0.2% in Australia to over 10% in some European nations. There are case reports of HIV being transmitted by sharing injecting equipment and sexual activity. Tattooing has been reported as a risk factor for the transmission of BBVs in prison. Access to condoms and needle and syringe programmes in prisons is extremely limited, despite success when they have been introduced. The vast majority of prison inmates are incarcerated for only a few months before returning to the community--thus they are, over the long term, more appropriately regarded as 'citizens' than 'prisoners'. Public health policy must involve all sections of the community, including prison inmates, if we are to reduce transmission of HIV and other BBVs.

[1]  D. Vlahov,et al.  Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland , 1993, European Journal of Epidemiology.

[2]  P. Sawanpanyalert,et al.  HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study , 2003, BMC infectious diseases.

[3]  M. Mahoney,et al.  An unusual presentation of Castleman's Disease:a case report , 2003, BMC infectious diseases.

[4]  K. Arriola,et al.  Male prisoners and HIV prevention: a call for action ignored. , 2003, American journal of public health.

[5]  A. Moss,et al.  Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study , 2003, BMJ : British Medical Journal.

[6]  K. Dolan,et al.  Prison-based syringe exchange programmes: a review of international research and development. , 2003, Addiction.

[7]  P. Sharps,et al.  The interrelationship between violence, HIV/AIDS, and drug use in incarcerated women. , 2003, The Journal of the Association of Nurses in AIDS Care : JANAC.

[8]  F. Molitor,et al.  Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. , 2002, AIDS.

[9]  Liz. Frost,et al.  Prisoner risk taking in the Russian Federation. , 2002, AIDS education and prevention : official publication of the International Society for AIDS Education.

[10]  Tanya Ehrmann.  Community-based organizations and HIV prevention for incarcerated populations: three HIV prevention program models. , 2002, AIDS education and prevention : official publication of the International Society for AIDS Education.

[11]  J. P. May,et al.  Acceptability of condom availability in a U.S. jail. , 2002, AIDS education and prevention : official publication of the International Society for AIDS Education.

[12]  Melanie J. Simmons,et al.  Intraprison HIV transmission: an assessment of whether it occurs, how it occurs, and who is at risk. , 2002, AIDS education and prevention : official publication of the International Society for AIDS Education.

[13]  A. Spaulding,et al.  Human immunodeficiency virus in correctional facilities: a review. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  D. D. Des Jarlais,et al.  Incarceration and Risk for HIV Infection Among Injection Drug Users in Bangkok , 2002, Journal of acquired immune deficiency syndromes.

[15]  N. Awofeso.  Jaggers in the pokey: understanding tattooing in prisons and reacting rationally to it. , 2002, Australian health review : a publication of the Australian Hospital Association.

[16]  M. Samuel,et al.  Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA , 2001, Epidemiology and Infection.

[17]  J. Parry,et al.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. , 2001, BMJ : British Medical Journal.

[18]  G. Godin,et al.  Correctional officers' intention of accepting or refusing to make HIV preventive tools accessible to inmates. , 2001, AIDS education and prevention : official publication of the International Society for AIDS Education.

[19]  S. M. Bird,et al.  Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study. , 2001, European journal of public health.

[20]  T. Makkai,et al.  Prevalence of tattooing and body piercing in the Australian community. , 2001, Communicable diseases intelligence quarterly report.

[21]  P. Haber,et al.  Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route , 2001, The Medical journal of Australia.

[22]  K. Dolan,et al.  Prison - Based Syringe Exchange Programs A Review of International Research and Program Development , 2001 .

[23]  L. Maruschak.  HIV in Prisons and Jails, 1999 , 2001 .

[24]  G. Godin,et al.  Correctional officers and prevention of HIV transmission among prisoners. , 2001, Canadian HIV/AIDS policy & law review.

[25]  C. Struckman‐Johnson,et al.  Sexual Coercion Rates in Seven Midwestern Prison Facilities for Men , 2000 .

[26]  J. Parry,et al.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey , 2000, BMJ : British Medical Journal.

[27]  Niyi Awofeso,et al.  Branded — Tattooing in Prisons , 2000, Tropical doctor.

[28]  J. Austin,et al.  HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group. , 2000, QJM : monthly journal of the Association of Physicians.

[29]  D. Shewan,et al.  Drug use and prisons : an international perspective , 2000 .

[30]  P. Fleming,et al.  Epidemiology of AIDS in incarcerated persons in the United States, 1994-1996. , 1999, AIDS.

[31]  J. Kaldor,et al.  HIV prevalence at reception into Australian prisons, 1991–1997 , 1999, The Medical journal of Australia.

[32]  P. Haber,et al.  Transmission of hepatitis C within Australian prisons , 1999, The Medical journal of Australia.

[33]  M. Levy.  Australian prisons are still health risks , 1999, The Medical journal of Australia.

[34]  K. Dolan,et al.  HIV transmission in a prison system in an Australian State , 1999, The Medical journal of Australia.

[35]  W. Hall,et al.  HIV risk behaviour and prevention in prison: a bleach programme for inmates in NSW , 1999 .

[36]  S. Hart.  Use of Adhesion Molecules for Gene Delivery , 1999, Nephron Experimental Nephrology.

[37]  K. Power,et al.  Injecting Drug Use Amongst Inmates in Greek Prisons , 1999 .

[38]  K. Dolan,et al.  A bleach program for inmates in NSW: an HIV prevention strategy , 1998, Australian and New Zealand journal of public health.

[39]  Y. Obadia,et al.  Survey of French prison found that injecting drug use and tattooing occurred , 1998, BMJ.

[40]  I. Guggenmoos‐Holzmann,et al.  History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. , 1997, International Journal of Epidemiology.

[41]  K. Dolan,et al.  Hepatitis B and C in New South Wales prisons: prevalence and risk factors , 1997, The Medical journal of Australia.

[42]  W. Hall,et al.  Hiv Risk Behaviour of Idus Before, During and After Imprisonment in New South Wales , 1996 .

[43]  W. Hall,et al.  Methadone maintenance reduces injecting in prison , 1996, BMJ.

[44]  W. Hall,et al.  Is a syringe exchange feasible in a prison setting? , 1996 .

[45]  N. Crofts,et al.  Risk Behaviours for Blood-borne Viruses in a Victorian Prison , 1996 .

[46]  C. Struckman‐Johnson,et al.  Sexual Coercion Reported by Men and Women in Prison , 1996 .

[47]  J. Inciardi,et al.  Sex in Prison: Exploring the Myths and Realities , 1995 .

[48]  D. Shewan,et al.  Patterns of injecting and sharing in a Scottish prison. , 1995, Drug and alcohol dependence.

[49]  J. Wrench,et al.  Outbreak of HIV infection in a Scottish prison , 1995, BMJ.

[50]  S. Locarnini,et al.  Spread of bloodborne viruses among Australian prison entrants , 1995, BMJ.

[51]  J. Moatti,et al.  HIV testing, HIV infection and associated risk factors among inmates in south-eastern French prisons , 1994, AIDS.

[52]  K. Stark,et al.  HIV prevalence and risk behaviour in injecting drug users in Berlin. , 1993, Forensic Science International.

[53]  W. Hall,et al.  Methadone maintenance treatment in prisons: The New South Wales Experience. , 1993, Drug and alcohol review.

[54]  C. Horsburgh,et al.  Seroconversion to human immunodeficiency virus in prison inmates. , 1990, American journal of public health.